Back to all bills
HR 2213119th CongressIntroduced
Medical Supply Chain Resiliency Act
Introduced: Oct 28, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Medical Supply Chain Resiliency Act authorizes the President to negotiate trade agreements that eliminate duties on medical goods to enhance national security and public health preparedness.
Key Points
- 1Authorizes reciprocal elimination of duties on medical goods with trusted trade partners
- 2Establishes criteria for selecting trusted trade partners based on reliability and IP protection
- 3Requires extensive congressional consultation and oversight before agreement implementation
- 4Provides for monitoring and enforcement of trade partner compliance
- 5Includes requirements for regular reporting to Congress on negotiations and implementation
- 6Creates a review process allowing Congress to disapprove agreements
Impact Areas
International trade policyMedical supply chain securityPharmaceutical and medical device industriesU.S. public health preparednessCongressional oversight of trade agreements
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025